Arana Therapeutics Announces Issuance of Key European Patent for Evibodies

SYDNEY, Australia, Feb. 8 2009: Antibody therapeutics company Arana Therapeutics Ltd (ASX:AAH) announced today that it has been awarded a patent by the European Patent Office for Evibodies™, small antibody-like proteins that can be used as drugs or diagnostic agents in applications where whole antibodies may be unsuitable.

MORE ON THIS TOPIC